News and Trends 28 Sep 2022
Ilya Pharma enrols first patient in diabetic foot ulcer study
Ilya Pharma AB says the first patients have been enrolled in a phase II study for its lead candidate ILP100-Topical in patients with diabetic foot ulcers. Overall, up to 13%…
